Zimmer Biomet Holdings, Inc.

ZBH

US98956P1021

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 04:00:03 2026-01-12 pm EST			5-day change	1st Jan Change
91.45 ^USD	-1.51%		-1.30%	+1.70%

Jan. 09	Zimmer Biomet Shares Dip After Bernstein Maintain	MT
Jan. 09	Zimmer Biomet Shares Dip After Bernstein Maintain	MT

Zimmer Biomet Receives 510(k) Clearance for Rosa Knee with OptimiZe

Published on 11/14/2025 at 08:14 am EST

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Zimmer Biomet Holdings, Inc.

Jan. 09	Zimmer Biomet Shares Dip After Bernstein Maintain	MT
Jan. 09	Zimmer Biomet Shares Dip After Bernstein Maintain	MT
Jan. 09	Bernstein Adjusts Price Target on Zimmer Biomet to $99 From $97, Maintains Market Perform Rating	MT
Jan. 09	Goldman Sachs Downgrades Zimmer Biomet to Sell From Neutral, Adjusts Price Target to $93 From $97	MT
Jan. 06	Trump Dreams Meet Market Reality
Jan. 06	Analyst recommendations: AT&T, BoA, Comcast, MetLife, Reddit…
Jan. 06	Evercore ISI Upgrades Zimmer Biomet Holdings to Outperform From In Line, Adjusts PT to $120 From $94	MT
Jan. 06	Raymond James Downgrades Zimmer Biomet to Market Perform From Outperform	MT
Dec. 19	Bactiguard Announces Updated Trauma License Agreement with Zimmer Biomet	CI
Dec. 19	Bactiguard Updates Licensing Agreement with Zimmer Biomet	FW
Dec. 19	Bactiguard updates license agreement with Zimmer Biomet	RE
Dec. 17	Zimmer Biomet Keeps Quarterly Dividend at $0.24 a Share, Payable Around Jan. 30 to Shareholders of Record on Dec. 30	MT
Dec. 17	Zimmer Biomet Holdings, Inc. Announces Quarterly Dividend for Fourth Quarter of 2025, Payable on or About January 30, 2026	CI
Dec. 17	Zimmer Biomet announces quarterly dividend for Q4 of 2025	RE
Dec. 17	North American Morning Briefing : Stock Futures, Oil Rise After Venezuela Blockade -2-	DJ
Dec. 16	Zimmer Biomet, OneStep Collaborating to Provide Mobility Data Tracking Joint Procedure Recovery	MT
Dec. 16	Baird Downgrades Zimmer Biomet Holdings to Neutral From Outperform, Adjusts PT to $100 From $117	MT
Dec. 16	Analyst recommendations: Accenture, Albemarle, Eli Lilly, Gitlab, Okta…
Dec. 11	Citigroup Adjusts Price Target on Zimmer Biomet Holdings to $94 From $98, Maintains Neutral Rating	MT
Dec. 05	Argus Research Adjusts Zimmer Biomet Price Target to $125 From $135, Maintains Buy Rating	MT
Nov. 18	Zimmer Biomet Holdings, Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 12:00 PM
Nov. 14	Zimmer Biomet Holdings, Inc. Receives U.S. FDA Clearance for Enhanced Version of Rosa Knee Robotic Technology	CI
Nov. 14	Zimmer Biomet Receives 510(k) Clearance for Rosa Knee with OptimiZe	MT
Nov. 06	Truist Cuts Price Target on Zimmer Biomet Holdings to $98 From $104, Keeps Hold Rating	MT
Nov. 06	UBS Adjusts Price Target on Zimmer Biomet to $88 From $96, Maintains Sell Rating	MT

Chart Zimmer Biomet Holdings, Inc.

Duration

Period

ZBH: Dynamic Chart

Zimmer Biomet Holdings, Inc. specializes in designing, manufacturing, and selling orthopedic reconstruction implants and traumatology products. Net sales break down by family of products as follows: - reconstruction implants (67.4%): knees replacement (61.4% of net sales), hips replacement (38.6%); - surgical products and traumatology equipment (24.3%); - other (8.3%): primarily orthopedic surgery materials and instruments used during post-operative rehabilitation. At the end of 2024, the group had approximately 25 production sites worldwide. Net sales are distributed geographically as follows: the United States (57.8%), Americas (4.7%), Europe/Middle East/Africa (22%) and Asia/Pacific (15.5%).

Employees

17,000

Sector

Medical Equipment, Supplies & Distribution

Calendar

11:15am - J.P. Morgan Healthcare Conference

More about the company